Company: MDCXW
Filing Date: 2025-12-01
Form Type: 424B3
Source: 0001062993-25-017095
Chunk: 3

Company: Medicus Pharma Ltd.
Filing Date: 2025-12-01
Form: 424B3
Chunk 3
---
 the Agreement, (iv) 90% of her base salary in her fourth year of employment under the Agreement and (v) 100% of her base salary in her fifth year of employment under the Agreement. Ms. Bonner is also eligible to receive Company stock options at the discretion of the board of directors of the Company or its compensation committee.

There are no family relationships between Ms. Bonner and any director or executive officer of the Company pursuant to Item 401(d) of Regulation S-K and the Company has not entered into any transactions with Ms. Bonner that are reportable pursuant to Item 404(a) of Regulation S-K. Except as described above, there are no arrangements or understandings between Ms. Bonner and any other persons pursuant to which she was selected as an executive officer of the Company.

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

| MEDICUS PHARMA LTD. |                                                |
| By:                 | /s/ Raza Bokhari                               |
| Name:               | Dr. Raza Bokhari                               |
| Title:              | Executive Chairman and Chief Executive Officer |

Dated: December 1, 2025